http://www.frost.com/prod/servlet/press-en-releases-index.pag?mkt=HC Press Releases - Healthcare en-us http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136333454 Despite issues such as rising R&D costs, poor reimbursement and a decline in prices, the emergence of new technologies is boosting the Western European in vitro diagnostics (IVD) markets. While the introduction of automation and integrated platforms has spurred mature segments such as clinical chemistry and immunoassay, new segments such as molecular diagnostics and point-of-care testing (POCT) are driving the overall market growth. Tue, 1 Jul 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136333454 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136334405 The sterilisation and disinfectant market in Europe has been witnessing slow growth as hospitals try to tackle alarmingly high infection rates resulting from inadequately decontaminated patient care equipment. However, the market is mature and saturated, offering little scope for technological innovation, and the complete lack of product differentiation is hampering competition. While the disinfection market has shown potential for expansion, the sterilisation market remains largely static. Tue, 1 Jul 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136334405 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136335053 In the past, healthcare executives were not supportive of remote patient monitoring (RPM) devices because of the costs involved. However, the quality and benefits of available RMP technology are making the devices increasingly attractive. Tue, 1 Jul 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136335053 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136337445 Based on its recent analysis of the biosensors market, Frost & Sullivan recognizes Integrity Applications Ltd. with the 2008 North American Frost & Sullivan Product Innovation Leadership of the Year Award for developing the world's first non-invasive glucose monitor , combining three diverse technologies together, GlucoTrack . Tue, 1 Jul 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136337445 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136170031 Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life. Mon, 30 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=136170031 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135585811 Nucleic acid-based amplification technique (NAT) has allowed the highly specific detection and quantification of extremely low levels of disease agents. This has supported effective therapeutic management through the monitoring of patients Tue, 24 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135585811 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135437524 As cadaveric bone implants have the same structural integrity as a normal human bone, they will integrate easily with the body and support the bodily functions well. Since it mimics the normal human bone in its chemical composition, these cadaveric implants, once sterilized and placed inside the human body, will allow easy joint fusion and integration using low-intensity pulse ultrasonic or magnetic stimulations. Additionally, to enable faster and effective integration of a cadaveric implant with another, or even with a normal bone, therapeutic bone growth factors are used. Mon, 23 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135437524 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135438101 Sales of glucose strips in North America have received a boost from enhanced awareness of the importance of blood glucose management, the greater implementation of tight glycemic control (TGC) protocols at point of care (POC) and the increasing number of diabetics. In order to gain a foothold, market entrants must offer innovative technologies. Mon, 23 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135438101 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135438565 Increased uptake of e-prescription and Electronic Medical Record (EMR) systems has significantly boosted the quality of healthcare and patient safety. Prescribers in the ambulatory care segment have increasingly realized their ability to save lives and costs through clinical automation as well as economical and consolidated e-prescribing systems. Backed by both excellent pre-sale and post-sale, services and support, e-prescribing systems currently enjoy unprecedented popularity. Mon, 23 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135438565 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135558780 Based on its recent analysis of the remote patient monitoring market, Frost & Sullivan presents Computerized Screening Inc. (CSI) with the 2008 North American Frost & Sullivan Award for Technology Leadership in recognition of its leadership and vision in the remote monitoring kiosks for community-based or population health disease management applications. Mon, 23 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=135558780 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134847728 C'e' bisogno di notevoli investimenti per i sistemi IT applicati ai servizi sanitari in Europa. Molti di questi programmi devono anche essere integrati con quelli esistenti al fine di garantirne un buon avvio. E' per questa ragione che i fornitori di soluzioni altamente scalabili e di integrazione di sistemi avranno la precedenza e saranno favoriti soprattutto se hanno esperienza nell'implementazione di grandi progetti. Tue, 17 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134847728 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134847674 Aby uzyskać autonomię finansową pozwalającą na inwestowanie w sprzęt do obrazowania medycznego, szpitale publiczne we Wschodniej Europie coraz częściej korzystają z usług prywatnych firm finansowych. Tego rodzaju Prywatne Inicjatywy Finansowe (PIF) zdobywają kapitał inwestycyjny, zwiększając tym samym perspektywy rozwoju istniejących rynk w środk w obrazowania medycznego. Mon, 16 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134847674 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134828146 Mon, 16 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134828146 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134395966 Public hospitals in Eastern Europe are increasingly approaching private finance service companies to gain financial autonomy, allowing them to invest in medical imaging equipment. These Private Financing Initiatives (PFIs) are raising investment capital and therefore improving the outlook for existing medical imaging modalities markets. Thu, 12 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134395966 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134286693 The present digitisation trend in Europe is promoting growth in the market for flat-panel detectors (FPDs). Superior image quality, low radiation exposure and enhanced workflow are some of the advantages of FPD-based imaging systems. The use of picture archiving and communication system (PACS) for picture archival systems and the adoption of healthcare IT solutions have also increased the demand for FPD-based systems in hospitals. Wed, 11 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134286693 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134287287 The European market for non-invasive blood pressure monitoring is witnessing steady growth as a result of improving awareness about the health risks of high blood pressure. There is now a greater acknowledgement of the need to be vigilant against abnormal blood pressure levels, increasing the practice of self monitoring among the general public. Wed, 11 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134287287 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134103817 Extensive cancer research reveals more than 90 percent of cancers occur due to genetic mutations. The complexity of molecular pathways indicates that cellular networks greatly coordinate and interconnect. This, in turn, essentially means that the non-functioning of any specific component in the cell proliferation pathway could result in several anomalies that could manifest as different cancers. Tue, 10 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134103817 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134161796 BIOMET 3i, a subsidiary of BIOMET, Inc. and a leader in the global dental implant market, is the recipient of the 2007 Frost & Sullivan European Dental Implant Customer Service Leadership Award. By winning this award, BIOMET 3i demonstrated excellence in all facets of customer service including providing exceptional support, offering outstanding technology and services, effectively responding to customer needs and successfully monitoring and addressing customer feedback. Tue, 10 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134161796 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134098475 The U.S. therapeutic monoclonal antibodies market is poised for a quantum leap with the launch of a multitude of new products and vigorous expansion of therapeutic indications of existing products. A combination of these factors, along with high demand and lack of generic competition, expects to create exciting new possibilities and ensure continued market growth. Mon, 9 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=134098475 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=133428327 Contract research organizations (CROs) hope to obtain an edge in the highly competitive healthcare industry by using technology to shorten project times, improve data quality, and thus, differentiate services. As clinical trials globalize, sponsor companies and CROs increasingly look for tools that will help them simultaneously view, manage and discuss these trials across multiple sites. Wed, 4 Jun 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=133428327 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132203515 The Kenyan antihypertensive market is growing at 5.5 per cent a year, driven by better economic prospects and lifestyle changes among a prospering middle class. However, the increasing entry of generic drug manufacturing firms is threatening the market share of big pharmaceutical companies. Fri, 30 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132203515 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132106533 The U.S. medical devices industry continues to witness solid growth, aided significantly by an ageing baby boomer population. Moreover, technological advancements such as the advent of minimally invasive surgery have altered the landscape for treatment. Medical device industries expect to continue to drive technological advancements as companies are investing heavily in research and development by devoting 7.9 percent of sales on such expenditures. Wed, 28 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132106533 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132106889 The introduction of image-guided and robot-assisted surgery (RAS) has sparked a revolution in the practice of medicine. The industry shift toward minimally invasive and laparoscopic procedures has taken a step further with the advent of these sophisticated systems. These systems essentially allow surgeons to successfully perform high-risk procedures in the smallest of anatomy; procedures that were nearly impossible a decade ago. Wed, 28 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132106889 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131916975 The Kenyan diabetes market is growing rapidly, primarily due to better diagnosis rates achieved through easier access to healthcare. Many type II diabetics in the country are also shifting towards the use of insulin along with their oral treatments. Tue, 27 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131916975 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131917047 Contracted services in the pharmaceutical industry are increasing due to challenges such as declining R&D productivity, increasing generic penetration, spiralling development costs and pipeline woes. The sharp rise in the number of biologicals paralleled by the expertise and cost savings offered by contract manufacturing organisations has underlined their appeal. Tue, 27 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131917047 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131917417 Price erosion, budgetary constraints, reimbursement issues and the cannibalisation of mechanical valves by tissue valves are all challenges facing the European heart valve repairs markets. However, the growth of tissue valves, paralleled by the rising popularity of minimally invasive techniques, will continue to drive the growth of this market. Tue, 27 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131917417 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131917485 The positive attitude of healthcare providers towards oncology information systems is growing as the European healthcare industry is looking for a broad mix of services and solutions. This situation is creating the potential for a multi-million dollar industry. Tue, 27 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=131917485 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132106427 The rising prevalence of cardiovascular conditions such as stroke, heart failure and coronary artery disease (CAD) hastens the development of suitable cardiovascular drug therapies among the elderly. The risks involved in surgeries on elderly patients and the existence of a patient category, in which long-term dietary control and physical activity are not sufficient or even appropriate, boost the prospects of cardiovascular drug therapies in both developed and developing nations. Tue, 27 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132106427 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132107100 The U.S. obesity surgery device market is keeping pace with fast-changing technologies, new scientific findings, and changing consumer demands to emerge a dynamic market. Patients no longer have to depend solely on diet and exercise to stay in shape and are progressively considering surgery as a near-instant cure for obesity. The availability of better treatment options, more accessible medical institutions, and better patient awareness are some motives fueling this trend. Tue, 27 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=132107100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130789925 Based on its recent analysis of the U.S. laboratory information management systems (LIMS) market, Frost & Sullivan presents Thermo Fisher Scientific with the 2008 North American Frost & Sullivan Award for Competitive Strategy Leadership. Fri, 23 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130789925 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130432446 Based on its recent analysis of the U.S. laboratory information management systems (LIMS) market, Frost & Sullivan recognizes Thermo Fisher Scientific with the 2008 North American Frost & Sullivan Award for Market Leadership for its commitment to innovation and growth. Mon, 19 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130432446 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130558767 The dramatic increase in the rate of cancer, coupled with the need for early detection, is driving the worldwide demand for biopsy devices. In Europe, the market for biopsy devices is facing challenges such as fierce competition and lack of reimbursements. Despite the dominance of tier I participants, there is still a significant level of competition among smaller participants for market share. Mon, 19 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130558767 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130558821 Growing awareness of the clinical and cost benefits of advanced wound care products is underlining their appeal and boosting their uptake. As healthcare expenditure on wound management soars, healthcare systems in eastern Europe are shifting from traditional wound care products to more advanced alternatives in a bid to achieve cost-effective, improved clinical management of wounds and reduce healthcare outlays. Mon, 19 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130558821 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130559334 Growing awareness of the clinical and cost benefits of advanced wound care products is underlining their appeal and boosting their uptake. As healthcare expenditure on wound management soars, healthcare systems in eastern Europe are shifting from traditional wound care products to more advanced alternatives in a bid to achieve cost-effective, improved clinical management of wounds and reduce healthcare outlays. Mon, 19 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130559334 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130563526 LONDRES, le 15 mai 2008 Ce qu'attendent les personnes atteintes d'un cancer du sein est un traitement. Plusieurs m dicaments sont actuellement utilis s pour traiter le cancer du sein aux stades III et IV. Cependant, ils agissent seulement pour bloquer la progression de la maladie et peuvent avoir des effets secondaires qui peuvent fortement perturber la vie quotidienne des patients. Lorsqu'ils sont efficaces, la tumeur peut tre contr l e pendant quelques ann es et le patient ne gagne que quelques ann es de vie. Cette situation cr e un besoin r el et imm diat pour une th rapie efficace et cibl e. Mon, 19 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130563526 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130392603 Frost & Sullivan Honors NDS Surgical Imaging for its Exceptional Branding Efforts, Backed by Pioneering Technology and Strong Product Suite Fri, 16 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130392603 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130224411 Life sciences funding is witnessing unprecedented increases in recent years, pressuring the EU to keep pace with the United States. The cohesion of research policies and funding channels across Europe will be necessary to achieve this objective. Thu, 15 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130224411 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130225304 A large pool of patients in Europe who have tried different alternatives but have been unsuccessful in losing excess weight are adopting obesity surgery. Growing awareness and the identification of this condition as a disease and not just an outcome of lifestyle have created a relatively strong market for these procedures. Such trends have provided a fillip to the uptake of related obesity surgery devices. Thu, 15 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130225304 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130257590 Considerable opportunities exist for e-clinical trial solutions. However, pharmaceutical companies should be convinced about the need for these solutions and the benefits of investing in them, as the entire industry is in a cost-cutting phase. E-clinical technology vendors, with highly scalable and cost-effective services and solutions, are well positioned to capture the market. Thu, 15 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130257590 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=129883334 The 2008 edition of the Frost & Sullivan Excellence in Healthcare Awards will see some of the region's illustrious names compete for the most coveted titles in the Asia Pacific Healthcare industry. Wed, 14 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=129883334 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=129923939 Frost & Sullivan recognizes Emageon with the 2007 Frost & Sullivan Technology Innovation Award in the field of unified and interconnected clinical image repository compliant with open standards. Emageon is commended for its 5.30.8 release offering superior software-based processing of medical images, aiding doctors in making advanced diagnosis from clinical images and other relevant patient data. Wed, 14 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=129923939 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130381072 Frost & Sullivan is launching a new end-user study on the preferences and drivers of adoption for various Enzyme-linked Immunosorbent Assays (ELISA) and Multiplex Technologies markets. Through more than 150 detailed interviews with a variety of pharmaceutical and biotechnology companies, academic institutions, reference laboratories, clinical laboratories and medical centers, Frost & Sullivan aims to elucidate key drivers and obstacles to adoption and utilization of ELISA and various multiplex technologies. Wed, 14 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&docid=130381072